Roka Bioscience, Inc. (NASDAQ:ROKA) major shareholder Orbimed Advisors Llc sold 201,617 shares of the business’s stock in a transaction that occurred on Tuesday, October 3rd. The stock was sold at an average price of $0.68, for a total value of $137,099.56. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Orbimed Advisors Llc also recently made the following trade(s):

  • On Friday, September 29th, Orbimed Advisors Llc sold 474,676 shares of Roka Bioscience stock. The stock was sold at an average price of $0.72, for a total value of $341,766.72.
  • On Wednesday, September 27th, Orbimed Advisors Llc sold 127,601 shares of Roka Bioscience stock. The stock was sold at an average price of $0.98, for a total value of $125,048.98.
  • On Wednesday, August 23rd, Orbimed Advisors Llc sold 1,100 shares of Roka Bioscience stock. The stock was sold at an average price of $1.50, for a total value of $1,650.00.
  • On Thursday, August 24th, Orbimed Advisors Llc sold 14,300 shares of Roka Bioscience stock. The stock was sold at an average price of $1.50, for a total value of $21,450.00.
  • On Tuesday, August 22nd, Orbimed Advisors Llc sold 75,276 shares of Roka Bioscience stock. The stock was sold at an average price of $1.52, for a total value of $114,419.52.

Shares of Roka Bioscience, Inc. (NASDAQ ROKA) traded up 2.844% on Thursday, hitting $0.781. The stock had a trading volume of 101,860 shares. Roka Bioscience, Inc. has a one year low of $0.66 and a one year high of $8.50. The company’s 50 day moving average is $1.12 and its 200 day moving average is $2.53. The stock’s market cap is $3.91 million.

WARNING: “Roka Bioscience, Inc. (ROKA) Major Shareholder Sells $137,099.56 in Stock” was posted by Watch List News and is the property of of Watch List News. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright laws. The correct version of this article can be read at https://www.watchlistnews.com/roka-bioscience-inc-roka-major-shareholder-sells-137099-56-in-stock/1611133.html.

A hedge fund recently raised its stake in Roka Bioscience stock. Sabby Management LLC boosted its position in Roka Bioscience, Inc. (NASDAQ:ROKA) by 6.5% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 389,136 shares of the medical research company’s stock after acquiring an additional 23,916 shares during the period. Sabby Management LLC owned about 7.77% of Roka Bioscience worth $1,374,000 at the end of the most recent reporting period. 66.51% of the stock is owned by institutional investors.

About Roka Bioscience

Roka Bioscience, Inc is a molecular diagnostics company. The Company is focused on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens under the Atlas brand name. The Company offers Atlas Detection Assays and Atlas instrument in the North American food safety testing market and has rights to develop and commercialize its molecular testing solutions for a range of other industrial applications.

Receive News & Ratings for Roka Bioscience Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roka Bioscience Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.